Scientific Program
07:30
Registration
08:50
Congress Opening & Welcome
Ralf Baron, Germany & Elon Eisenberg, Israel - Congress Co-Chairs
09:00-10:30
Session 1: Challenging in Clinical Trials on Acute and Chronic Pain
Moderator: Ralf Baron, Germany
09:00-09:30
Topical medication for neuropathic pain: challenges in trial design
Nadine Attal
Ambroise Paré Hospital, Boulogne-Billancourt, France
09:30-10:00
Epidemiology of chronic pain: Impact on clinical trials
Didier Bouhassira
National Institute for Health and Medical Research (Inserm), France
10:00-10:30
Acute postoperative pain trial designs: lessons learned from PAINOUT thus far
Winfried Meissner
Jena University Hospital, Germany
10:30-11:00
Coffee Break & Poster Viewing
11:00-12:30
Session 2: News From Bench Labs
Moderator: Elon Eisenberg, Israel
11:00-11:45
Sensory modulation disorders and pain: an animal experimental view
Anthony Dickenson
University College London (UCL), UK
11:45-12:30
Stem cells in pain trials
Angelika Lampert
University Hospital RWTH Aachen, Germany
12:30-13:30
Lunch Break & Poster Viewing
13:30-14:40
Session 3: Free Paper Presentations
Moderator: Ralf Baron, Germany
| 13:30-13:40 | The Effect of Microbiota and Related Blood Tryptophan Metabolites on Pain In Patients Undergoing Lumbar Disc Herniation Surgery - Yunus Celik, Turkey |
| 13:40-13:50 | Sensory Phenotypes of 612 patients with Complex Regional Pain Syndrome - Julia Forstenpointner, Germany |
| 13:50-14:00 | Clinical Proof-Of-Concept of LAT8881 as a First-In-Class Non-Opioid Treatment for Chronic Moderate-to-Severe Lumbar Radicular Pain - Stuart Mudge, Australia |
| 14:00-14:10 | Adverse Drug Reactions Associated with the Prescription of Oral Cannabis-Based Medicinal Products: A Post-Marketing Pharmacovigilance Study - Guillermo Moreno Sanz, Spain |
| 14:10-14:20 | Enhancing Quality of Life in Painful Diabetic Peripheral Neuropathy (PDPN): Multi-Centre Clinical Trial of Duloxetine and Pregabalin - Martin Rakusa, Slovenia |
| 14:20-14:30 | AmyloScan® – A simple screening tool for hereditary transthyretin amyloidosis - Manon Sendel, Germany |
| 14:30-14:40 | Harnessing Artificial Intelligence/Machine Learning in Rare Diseases: Living with Arachnoiditis - an International Study by Arachnoiditis & Chronic Meningitis Collaborative Research Network (ACMCRN) - Ishna Singh on behalf of Lori Verton, Canada (Pre-recorded) |
14:40-15:15
Coffee Break & Poster Viewing
15:15-16:45
Session 4: More on Challenges and Opportunities
Moderator: Elon Eisenberg, Israel
15:15-15:45
Is nerve regeneration a new chance for pain treatment?
Ralf Baron - Congress Co-Chair
UKSH Universitätsklinikum Schleswig-Holstein, Germany
15:45-16:15
Heterogeneity in chronic pain: Considerations for clinical trial design
Jennifer Gewandter
University of Rochester School of Medicine and Dentistry, USA
16:15-16:45
Integrating real-world data into clinical trials: methods, use cases, and limitations
Jan Vollert
Imperial College London, UK
08:00
Registration
09:00-10:30
Session 5: Clinical Trials Designs and Outcomes
Moderator: Ralf Baron, Germany
09:00-09:30
Domains and PROMs assessed in pain trials related to endometrioses
Daniela Rosenberger
Universitätsklinikum Münster (UKM), Germany
09:30-10:00
Pragmatic Pain Trials
Elon Eisenberg - Congress Co-Chair
Technion - Israel Institute of Technology, Israel
10:00-10:30
Design of combination trials in pain
Solomon Tesfaye
Sheffield Teaching Hospitals and University of Sheffield, UK
10:30-11:00
Coffee Break & Poster Viewing
11:00-12:30
Session 6: Objective Pain Measures in Clinical Trials
Moderator: Elon Eisenberg, Israel
11:00-11:30
Can functional MRI be a biomarker in Clinical Trials on Pain?
Irit Weissman-Fogel
University of Haifa, Israel
11:30-12:00
Wearables in clinical trials for pain
Walter Maetzler
University Hospital in Kiel, Germany
12:00-12:30
Serum metabolic profiling: a potential pain biomarker in pain in osteoarthritis?
David Walsh
University of Nottingham, UK
12:30-13:30
Lunch Break & Poster Viewing
13:30-15:00
Session 7: Placebo, Nocebo
Moderator: Ralf Baron, Germany
13:30-14:15
The placebo response in the context of drug development programs (
)
) 
Roi Treister
University of Haifa, Israel
14:15-15:00
Avoiding placebo and nocebo in non-pharmacological clinical trials
David Hohenschurz-Schmidt
Imperial College London, UK
15:00-15:30
Coffee Break, Exhibition & Poster Viewing
15:30-16:00
The following presentation is not included in the CME Accreditation
15:30-16;00
Holistic approach for clinical development of new products for pain treatment
Irena Pulte
Merz Therapeutics, Germany
16:00
Best Abstract Award Recipient Announcement
16:10
Congress Closing Remarks
Ralf Baron, Germany & Elon Eisenberg, Israel - Congress Co-Chairs
